In another study, lower Kyn serum concentrations (a byproduct of IDO1 activity) in ER+ patients at the time of diagnosis were correlated with low or absent IDO1 mRNA and protein expression in ER+ BC tissues, while the opposite was observed in ER− tumors [71]. The gene discussed is IDO1; the disease is breast cancer.